Feedback / Questions
ONCT-808 - Ho’ola Therapeutics
zilovertamab (UC-961) - Ho’ola Therapeutics
https://www.globenewswire.com/news-release/2025/07/01/3108259/0/en/Oncternal-Therapeutics-Announces-the-Sale-of-Select-Development-Programs-and-the-Wind-Down-of-its-Operations.html
Jul 1, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next